Dr. Samantha Lynn Schneider, MD

Dr. Schneider practices at LMC Pathology Services - Las Vegas (W Washington Ave) in Las Vegas, Nevada.

Dr. Schneider's NPI, 1992190235, was assigned on April 3, 2015. Dr. Schneider graduated from Albert Einstein College of Medicine in 2015. Dr. Schneider holds Nevada license 19793.

Dr. Schneider's primary practice is LMC Pathology Services - Las Vegas (W Washington Ave), at 7455 W Washington Ave Ste 301, Las Vegas, NV 89128. The practice phone is (702) 732-3441.

Dr. Schneider's primary practice is LMC Pathology Services - Las Vegas (W Washington Ave) in Las Vegas, Nevada. The medical group on file is Pacific Crest Dermatology. Dmand AI also links Dr. Schneider to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schneider practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Schneider's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Schneider is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Schneider's licenses on file in 6 states: Nevada, California, Alaska, Missouri, Michigan and Colorado.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and itchy rashes among the conditions Dr. Schneider treats.

CMS data shows 1,388 Medicare services from Dr. Schneider across 20 procedure codes in 2024, for 237 Medicare patients. Medicare paid $146,833 for them. Every service was in an office.

CMS counts 237 Medicare patients who saw Dr. Schneider in 2024. The largest group is 65 to 74, with 127 patients. 73% of them have high cholesterol, and 57% have high blood pressure. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schneider's median patient age at 66, with 58% women.

In 2024, Dr. Schneider wrote 165 Medicare Part D claims for 80 patients. 95% of them were for generic drugs. CMS names the drug for 80 of them, across 4 drugs with 11 or more claims each, at $1,872 in total drug cost.

Dr. Schneider accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 572 procedures of removal of skin lesions by Dr. Schneider, more than 88% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 18 papers to Dr. Schneider, published from 2014 to 2022. 2014 was the busiest year, with 2. The most frequent topics are Skin Neoplasms, Nail Diseases and Papilloma. Dr. Schneider has published most often in JAAD Case Rep. Dr. Schneider's most frequent co-authors are James M. Grichnik, MD, Ellen N. Pritchett and Pranita Vemulapalli Rambhatla, MD.

CMS Open Payments shows 40 general payments to Dr. Schneider from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $255.

Dr. Schneider graduated from Albert Einstein College of Medicine in 2015. Dr. Schneider is a member of AOA, AAD and ASDS.

Dr. Schneider is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.